[Polypharmacy in dermatology].

Authors

Michael Sticherling

Published in

Dermatologie (Heidelberg, Germany). Oct 27, 2026. Epub Oct 27, 2026.

Abstract

Polypharmacy is defined as the long-term use of more than five medications. Given current advances in treatment, it poses a challenge in patient care. Polypharmacy can be appropriate and justifiable in cases of complex or multiple concurrent conditions (multimorbidity), but if initiated without due caution, it can also lead to significant adverse reactions. In addition, the economic costs associated with unnecessary medication are significant. Polypharmacy is also particularly relevant in dermatology from various perspectives. Many systemic medications can cause adverse skin reactions or induce skin diseases. Conversely, the systemic treatment of skin diseases-particularly in chronically ill, multimorbid, and elderly patients-must be coordinated with internal medicine medications and requires mutual information sharing and cooperation among all healthcare providers. Medication regimens should therefore be reviewed regularly and critically for the benefit of patients.

PMID:
42944873
Bibliographic data and abstract were imported from PubMed on 28 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.